The Evidence Space

With Dr Ronjon Nag and Martin Hunt.Evidencing long-term value to funders as well as patients and clinicians.In the last episode we discussed the different types of funding, what investors are looking for, and what developers should understand to attract investment. In this episode, we continued the conversation with Ronjon and Martin on what comes next: how you can build your team and scale up or expand once you’ve seen real patient benefits, and what comes at the end of the journey.Over the ...

Convincing investors to put their money where their health is.With Dr Ronjon Nag and Martin Hunt.Throughout this series we've learned about the various steps that are involved in developing and validating new innovations for health care and life sciences. Many of these activities can take a significant amount of time bringing with them an equally significant cost. So, how do you fund these activities and sustain a business until you start generating revenue?To help us answer these questions a...

Understanding the importance of intuitive design for effective solutions.With Bastian Hauck and Dr Tahreema Matin.On this week’s episode we continued the conversation with Bastian Hauck and Dr Tahreema Matin considering ways to improve the development of healthcare innovations. In the previous episode we looked at the importance of collaborating with users in the early stages of device development. In this episode we discuss the role of innovators to create solutions that can be easily used, ...

Exploring the value of user-led co-design for engineers and technologists.With Bastian Hauck and Dr Tahreema Matin.On this week’s episode of The Evidence Space we look at the importance of designing healthcare innovations that work for the intended user and what steps can be taken to achieve this. There are different approaches when developing new technologies for use by a clinician versus a patient, therefore different designing interventions need to be in place. How can we better understand...

How technical innovations can address the challenges in participant recruitment and retention for clinical trials during COVID-19 and beyond.With Dr Adam M Hill and Jeff Ventimiglia.On this week’s episode, we continued the conversation with Adam M Hill and Jeff Ventimiglia on clinical trials, focusing on the role of participants. COVID-19 has made it more challenging to find participants for clinical trials, but technology has created new opportunities. We discussed the benefits of patients t...

Examining the role of clinical trials in building confidence in new devices, diagnostics and drugs.With Dr Adam M Hill and Jeff Ventimiglia.On this episode, we tackle the topic of clinical trials. Clinical trials are often used to show the effectiveness of treatments such as drugs or surgical procedures. But how and when are clinical trials necessary to show that new technologies for health and care deliver the results that they claim? We spoke with Dr Adam M Hill and Jeff Ventimiglia to disc...

The second part of our two-part podcast – driving forward the standard of care using cutting-edge technology while maintaining safety and performance standards.With Eleonora Harwich and Claudia MartinezIn healthcare, there remains a gap between the review of regulations and meeting them in a practical sense. Manufacturers need to fully describe the intended use of their device to allow them to identify the rules that apply, and the compliance that needs to be demonstrated. On this week’s epis...

Looking at the role of regulation in the development of innovation in healthcare and differentiating between mandatory rules and optional practical guidance. Within the UK and globally, there's been a rapid adoption of digital health technologies. As in several other industries such as manufacturing, transport, or the energy sector, healthcare technology is highly regulated. Standards and guidance for regulation are in place but how do patients know that manufacturers are abiding to them...

The second part of our two-part podcast - design safety in healthcare technologies, mitigating design challenges and the potential harm in digital health interventions.With Dr Matthew Fenech and Stuart Harrison We continued the conversation with Dr Matthew Fenech and Stuart Harrison about clinical safety. On this week’s episode, we looked at the meaning of ‘Safety by design’, mitigating design challenges, how manufactures can demonstrate safety in innovations and more.

The importance of clinical safety and how manufacturers can ensure that it is present when their devices or new treatments are in use.With Dr Matthew Fenech and Stuart Harrison Throughout this series, we’ve started to understand that one of the key aims of clinical testing for medical devices or new therapies, is to ensure that not only is it effective, but also that it is safe and doesn’t have any unintended harmful consequences. In this week’s episode, we focused on clinical safety; wh...